<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>Canadian PKU and Allied Disorders - Articles</title>
		<link>http://www.canpku.org/</link>
		<description>Articles from Canadian PKU and Allied Disorders</description>
		<pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
		<language>en</language> 
		<item>
			<title>QU’s genetic discovery offers new hope for treating Homocystinuria</title>
			<link>http://www.canpku.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=25</link>
			<pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
			<category>HCU - Homocystinuria/  L’homocystinurie</category> 
			<guid isPermaLink="false">http://www.canpku.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=25</guid>
			<description>This article is presented in English. The article comes from Tribune News Network, Doha.
Cet article est presente en anglais. L&apos;article provient de Tribune News Network, Doha.
Researchers from Qatar University (QU) published a study examining a specific genetic mutation called T236N in the CBS (cystathionine beta-synthase) enzyme.
</description>
		</item>
		
	</channel>
</rss> 